SCHEMBL10575604

SCHEMBL10575604

COc1cc([S+](C)[O-])ccc1-c1nc2cc(C(C)(C)CNC=O)ccc2[nH]1

nearest known ligand 0.34

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ PDE5A O76074 3/20 0.34
▸ PDE3B Q13370 2/20 0.34
▸ PDE3A Q14432 2/20 0.34
▸ AMY1A P0DUB6 7/20 0.33
▸ PDE2A O00408 1/20 0.31
▸ KDM4E B2RXH2 1/20 0.30
▸ MEN1 O00255 1/20 0.30
▸ ALDH1A1 P00352 1/20 0.30
▸ LMNA P02545 1/20 0.30
▸ CYP1A2 P05177 1/20 0.30
▸ HPGD P15428 1/20 0.30
▸ KMT2A Q03164 1/20 0.30
▸ HSD17B10 Q99714 1/20 0.30
▸ NPC1 O15118 1/20 0.30
▸ RAB9A P51151 1/20 0.30
▸ SLC2A1 P11166 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10575621 0.93 AMY1A (0.36) PDE5APDE3BPDE3AAMY1A
SCHEMBL10578728 0.87 NR1I2 (0.34) PDE5APDE3BPDE3AAMY1APDE2A
SCHEMBL10574093 0.85 AMY1A (0.43) PDE5APDE3BPDE3AAMY1AKDM4E
SCHEMBL10579306 0.85 CDK4 (0.38) PDE5APDE3BPDE3AAMY1AMEN1
SCHEMBL10580104 0.84 PDE5A (0.45) PDE5AAMY1ANPC1RAB9ASLC2A1
SCHEMBL10577353 0.84 NPC1 (0.37) PDE5APDE3BPDE3AAMY1APDE2A
SCHEMBL10578096 0.82 AMY1A (0.37) PDE5APDE3BPDE3AAMY1APDE2A
SCHEMBL10765920 0.81 AMY1A (0.39) PDE5APDE3BPDE3AAMY1APDE2A
SCHEMBL10578739 0.80 AMY1A (0.36) PDE5APDE3BPDE3AAMY1A
SCHEMBL10578360 0.79 AMY1A (0.34) AMY1AALDH1A1HPGDNPC1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4882342-A CARDIOVASCULAR DISORDERS BOEHRINGER MANNHEIM GMBH (DE) 1989-11-21 — — US disclosed
EP-0266558-A2 5-Alkylbenzimidazoles, process for their preparation and medicaments containing them Roche Diagnostics GmbH (DE) 1988-05-11 — — EP disclosed
Send feedback